Polaryx Therapeutics Inc. Common Stock

PLYX | NASDAQ

$1.75

-$0.11 (-5.91%)

At close: Oct 30, 2026, 4:00 PM ET

$1.85

+$0.10 (+5.71%)

After-hours: Oct 30, 2026, 7:31 PM ET

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023
PE Ratio	-184.21	-218.75	-1.75K
PEG Ratio	-9.82	-0.31	n/a
PS Ratio	n/a	n/a	n/a
PB Ratio	362.98	1.41K	5.19K
P/FCF Ratio	-420.14	-2.58K	-38.31K
P/OCF Ratio	-420.14	-2.58K	-38.31K
OCF/S Ratio	n/a	n/a	n/a
Debt / Equity Ratio	n/a	n/a	0.10
Quick Ratio	8.55	17.30	2.23
Current Ratio	8.55	17.30	2.23
Asset Turnover	n/a	n/a	n/a
Interest Coverage	n/a	n/a	n/a
Return on Equity	-196.82%	-644.23%	-295.93%
Return on Assets	-165.77%	-607%	-163.24%
Return on Invested Capital	-162.43%	-92.36%	-269.11%
Dividend Yield	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a